RSV vaccine study for kids: lower dose may work just as well
NCT ID NCT06705140
First seen Feb 03, 2026 · Last updated May 09, 2026 · Updated 13 times
Summary
This study tested a respiratory syncytial virus (RSV) vaccine in healthy infants and toddlers aged 6 to 22 months. The goal was to see if a lower dose of the vaccine triggers a similar immune response as the standard dose, and to check the safety of different doses. The vaccine was given as a nasal spray, and participants were monitored for side effects and antibody levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RSV IMMUNISATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number : 2140002
Santo Domingo, 10201, Dominican Republic
-
Investigational Site Number : 3400001
Tegucigalpa, 11101, Honduras
-
Investigational Site Number : 3400002
San Pedro Sula, Honduras
-
Investigational Site Number : 3400003
Tegucigalpa, 11101, Honduras
Conditions
Explore the condition pages connected to this study.